Reply to Itzhaki
Open Access
- 29 January 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 211 (12) , 2024
Abstract
To the Editor—We thank Drs Itzhaki and Klapper for their interest in and comments regarding our study [1], which examined the relationship between cytomegalovirus (CMV) infection and risk of Alzheimer's disease (AD). We found that CMV seropositivity was associated with a 2-fold increase in risk of AD and a faster rate of cognitive decline. The results were robust to a number of covariates, including herpes simplex virus type 1 (HSV-1). In addition, our findings support earlier cohort studies that have examined the association between CMV and cognitive function [2, 3]. Together, these studies suggest a potential role for CMV as a factor that may influence cognition and risk of AD in older ages.Keywords
This publication has 4 references indexed in Scilit:
- Herpes simplex virus type 1 and Alzheimer’s disease: increasing evidence for a major role of the virusFrontiers in Aging Neuroscience, 2014
- Cytomegalovirus Infection and Risk of Alzheimer Disease in Older Black and White IndividualsThe Journal of Infectious Diseases, 2014
- The Influence of Latent Viral Infection on Rate of Cognitive Decline over 4 YearsJournal of the American Geriatrics Society, 2006
- Impact of Viral and Bacterial Burden on Cognitive Impairment in Elderly Persons With Cardiovascular DiseasesStroke, 2003